RecruitingPhase 3NCT07654374
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Omaha, NE · +73 more sites
Obesity clinical trials in Omaha, NE
9 recruiting obesity studies with a site in Omaha, NE.
RecruitingPhase 3NCT07595549
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Sponsor: Pfizer
Omaha, NE · +34 more sites
RecruitingPhase 2NCT07685808
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Sponsor: Regeneron Pharmaceuticals
Omaha, NE · +20 more sites
RecruitingPhase 3NCT07037433
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Sponsor: Amgen
Lincoln, NE · Omaha, NE · Papillion, NE · +137 more sites
RecruitingPhase 3NCT06672549
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Sponsor: Eli Lilly and Company
Omaha, NE · +48 more sites
RecruitingPhase 3NCT07784270
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Sponsor: AstraZeneca
Omaha, NE · +52 more sites
RecruitingPhase 3NCT07037459
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Sponsor: Amgen
Lincoln, NE · Omaha, NE · +119 more sites
RecruitingPhase 3NCT07654361
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Omaha, NE · +70 more sites
RecruitingNot applicableNCT06888011
iAmHealthy Clinical Practice Guideline (CPG)
Sponsor: University of Kansas Medical Center
Omaha, NE · +3 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.